Tardive Dyskinesia (TD) Treatment Drugs Market Report

Global and Region Tardive Dyskinesia (TD) Treatment Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：207
  • REPORT CODE：GMM963391
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Tardive Dyskinesia (TD) Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Tardive Dyskinesia (TD) Treatment Drugsmarket, defines the market attractiveness level of Tardive Dyskinesia (TD) Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Tardive Dyskinesia (TD) Treatment Drugs industry, describes the types of Tardive Dyskinesia (TD) Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tardive Dyskinesia (TD) Treatment Drugs market and the development prospects and opportunities of Tardive Dyskinesia (TD) Treatment Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tardive Dyskinesia (TD) Treatment Drugs market in Chapter 13.

    By Player:

    • Biogen

    • AstraZeneca

    • Bayer AG

    • Sanofi

    • GlaxoSmithKline plc

    • Teva Pharmaceutical Industries

    • Novartis AG

    • Pfizer Inc

    • Neurocrine Biosciences Inc

    By Type:

    • Valbenazine

    • Deutetrabenazine

    By End-User:

    • Hospitals

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Tardive Dyskinesia (TD) Treatment Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Tardive Dyskinesia (TD) Treatment Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Tardive Dyskinesia (TD) Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Tardive Dyskinesia (TD) Treatment Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Tardive Dyskinesia (TD) Treatment Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    • 7.2 United States Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    • 7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    • 7.4 China Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    • 7.5 Japan Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    • 7.6 India Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    • 7.7 South Korea Tardive Dyskinesia (TD) Treatment Drugs Consumption (2017-2022)

    8 Region and Country-wise Tardive Dyskinesia (TD) Treatment Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    • 8.4 China Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    • 8.6 India Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast (2022-2028)

    9 Global Tardive Dyskinesia (TD) Treatment Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Valbenazine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Deutetrabenazine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Tardive Dyskinesia (TD) Treatment Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Valbenazine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Deutetrabenazine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Tardive Dyskinesia (TD) Treatment Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Tardive Dyskinesia (TD) Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Tardive Dyskinesia (TD) Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Tardive Dyskinesia (TD) Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Tardive Dyskinesia (TD) Treatment Drugs Market Competitive Analysis

    • 14.1 Biogen

      • 14.1.1 Biogen Company Details

      • 14.1.2 Biogen Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.5 GlaxoSmithKline plc

      • 14.5.1 GlaxoSmithKline plc Company Details

      • 14.5.2 GlaxoSmithKline plc Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline plc Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.6 Teva Pharmaceutical Industries

      • 14.6.1 Teva Pharmaceutical Industries Company Details

      • 14.6.2 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.7 Novartis AG

      • 14.7.1 Novartis AG Company Details

      • 14.7.2 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.8 Pfizer Inc

      • 14.8.1 Pfizer Inc Company Details

      • 14.8.2 Pfizer Inc Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Inc Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • 14.9 Neurocrine Biosciences Inc

      • 14.9.1 Neurocrine Biosciences Inc Company Details

      • 14.9.2 Neurocrine Biosciences Inc Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Neurocrine Biosciences Inc Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Tardive Dyskinesia (TD) Treatment Drugs

    • Figure Tardive Dyskinesia (TD) Treatment Drugs Picture

    • Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Tardive Dyskinesia (TD) Treatment Drugs Consumption by Country (2017-2022)

    • Figure United States Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tardive Dyskinesia (TD) Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tardive Dyskinesia (TD) Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valbenazine Consumption and Growth Rate (2017-2022)

    • Figure Global Deutetrabenazine Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Valbenazine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deutetrabenazine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Tardive Dyskinesia (TD) Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Tardive Dyskinesia (TD) Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Tardive Dyskinesia (TD) Treatment Drugs Product and Service

    • Table Neurocrine Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Neurocrine Biosciences Inc Tardive Dyskinesia (TD) Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurocrine Biosciences Inc Tardive Dyskinesia (TD) Treatment Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US